101 related articles for article (PubMed ID: 8395203)
1. Sequence-specific resonance assignments of the 1H-NMR spectra of a synthetic, biologically active EIAV Tat protein.
Willbold D; Krüger U; Frank R; Rosin-Arbesfeld R; Gazit A; Yaniv A; Rösch P
Biochemistry; 1993 Aug; 32(33):8439-45. PubMed ID: 8395203
[TBL] [Abstract][Full Text] [Related]
2. Equine infectious anemia virus Tat is a predominantly helical protein.
Sticht H; Willbold D; Bayer P; Ejchart A; Herrmann F; Rosin-Arbesfeld R; Gazit A; Yaniv A; Frank R; Rösch P
Eur J Biochem; 1993 Dec; 218(3):973-6. PubMed ID: 7506657
[TBL] [Abstract][Full Text] [Related]
3. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
Mujeeb A; Parslow TG; Yuan YC; James TL
J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of the equine infectious anemia virus trans-activator protein.
Willbold D; Volkmann A; Metzger AU; Sticht H; Rosin-Arbesfeld R; Gazit A; Yaniv A; Frank RW; Rösch P
Eur J Biochem; 1996 Aug; 240(1):45-52. PubMed ID: 8797834
[TBL] [Abstract][Full Text] [Related]
5. Structure of the equine infectious anemia virus Tat protein.
Willbold D; Rosin-Arbesfeld R; Sticht H; Frank R; Rösch P
Science; 1994 Jun; 264(5165):1584-7. PubMed ID: 7515512
[TBL] [Abstract][Full Text] [Related]
6. Equine infectious anemia virus transactivator is a homeodomain-type protein.
Willbold D; Metzger AU; Sticht H; Gallert KC; Voit R; Dank N; Bayer P; Krauss G; Goody RS; Rösch P
J Mol Biol; 1998 Apr; 277(4):749-55. PubMed ID: 9545368
[TBL] [Abstract][Full Text] [Related]
7. NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat.
Mujeeb A; Bishop K; Peterlin BM; Turck C; Parslow TG; James TL
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8248-52. PubMed ID: 8058789
[TBL] [Abstract][Full Text] [Related]
8. Trifluoroethanol stabilizes a helix-turn-helix motif in equine infectious-anemia-virus trans-activator protein.
Sticht H; Willbold D; Ejchart A; Rosin-Arbesfeld R; Yaniv A; Gazit A; Rösch P
Eur J Biochem; 1994 Nov; 225(3):855-61. PubMed ID: 7957222
[TBL] [Abstract][Full Text] [Related]
9. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
Derse D; Dorn P; DaSilva L; Martarano L
Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein.
Sharma A; Bruns K; Röder R; Henklein P; Votteler J; Wray V; Schubert U
BMC Struct Biol; 2009 Dec; 9():74. PubMed ID: 20015412
[TBL] [Abstract][Full Text] [Related]
11. Structural studies of HIV-1 Tat protein.
Bayer P; Kraft M; Ejchart A; Westendorp M; Frank R; Rösch P
J Mol Biol; 1995 Apr; 247(4):529-35. PubMed ID: 7723010
[TBL] [Abstract][Full Text] [Related]
12. Is EIAV Tat protein a homeodomain?
Rösch P; Willbold D
Science; 1996 Jun; 272(5268):1672. PubMed ID: 8658146
[No Abstract] [Full Text] [Related]
13. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
Derse D; Newbold SH
Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
[TBL] [Abstract][Full Text] [Related]
14. Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.
Taube R; Fujinaga K; Irwin D; Wimmer J; Geyer M; Peterlin BM
J Virol; 2000 Jan; 74(2):892-8. PubMed ID: 10623752
[TBL] [Abstract][Full Text] [Related]
15. Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat.
Anand K; Schulte A; Fujinaga K; Scheffzek K; Geyer M
J Mol Biol; 2007 Jul; 370(5):826-36. PubMed ID: 17540406
[TBL] [Abstract][Full Text] [Related]
16. Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization.
Loret EP; Vives E; Ho PS; Rochat H; Van Rietschoten J; Johnson WC
Biochemistry; 1991 Jun; 30(24):6013-23. PubMed ID: 2043639
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulation of equine infectious anemia virus Tat protein in water and in 40% trifluoroethanol.
Sticht H; Willbold D; Rösch P
J Biomol Struct Dyn; 1994 Aug; 12(1):019-36. PubMed ID: 7848558
[TBL] [Abstract][Full Text] [Related]
18. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.
Schiltz RL; Shih DS; Rasty S; Montelaro RC; Rushlow KE
J Virol; 1992 Jun; 66(6):3455-65. PubMed ID: 1316461
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and intracellular location of the Tat protein of equine infectious anemia virus.
Rosin-Arbesfeld R; Mashiah P; Willbold D; Rosch P; Tronick SR; Yaniv A; Gazit A
Gene; 1994 Dec; 150(2):307-11. PubMed ID: 7821797
[TBL] [Abstract][Full Text] [Related]
20. Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.
Loret EP; Georgel P; Johnson WC; Ho PS
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9734-8. PubMed ID: 1409690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
